Correction of a release from 25.09.2017, 17:05 CET/CEST - Sartorius AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
March 20, 2018 at 09:40 am EDT
Share
DGAP Voting Rights Announcement: SARTORIUS AG
Correction of a release from 25.09.2017, 17:05 CET/CEST - Sartorius AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
20.03.2018 / 14:34
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Correction of a notification of Major Holding published on 25.09.2017
1. Details of issuer
SARTORIUS AG
Otto-Brenner-Straße 20
37079 Göttingen
Germany
2. Reason for notification
Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
X
Other reason: Change in execution of last will
3. Details of person subject to the notification obligation
Name:
City and country of registered office:
Mr Dr. Lothar Kappich, Date of birth: 15 Feb 1957
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Karin Sartorius-Herbst, Christine Franken, Ulrike Baro, Andreas Franken, Kai Christian Franken (in Erbengemeinschaft)
5. Date on which threshold was crossed or reached:
08 Sep 2017
6. Total positions
% of voting rights attached to shares (total of 7.a.)
% of voting rights through instruments (total of 7.b.1 + 7.b.2)
total of both in % (7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation
50.09 %
0 %
50.09 %
37,440,000
Previous notification
n/a %
n/a %
n/a %
/
7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
ISIN
absolute
in %
direct (Sec. 33 WpHG)
indirect (Sec. 34 WpHG)
direct (Sec. 33 WpHG)
indirect (Sec. 34 WpHG)
DE0007165607
0
18754160
0 %
50.09 %
Total
18,754,160
50.09 %
b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Voting rights absolute
Voting rights in %
%
Total
%
b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Cash or physical settlement
Voting rights absolute
Voting rights in %
%
Total
%
8. Information in relation to the person subject to the notification obligation
X
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name
% of voting rights (if at least held 3% or more)
% of voting rights through instruments (if at least held 5% or more)
Total of both (if at least held 5% or more)
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
Date of general meeting:
Holding position after general meeting:
% (equals voting rights)
10. Other explanatory remarks:
Notification due to the death of the former executor Prof. Dr. Arnold Picot on July 9, 2017, and appointment of Dr. Kappich as his successor, effective as of September 8, 2017.
20.03.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
SARTORIUS AG 
